Gastroenterology

Gastroenterology

Volume 137, Issue 2, August 2009, Pages 404-409
Gastroenterology

Mini-Review and Perspective
Concepts in Familial Colorectal Cancer: Where Do We Stand and What Is the Future?

https://doi.org/10.1053/j.gastro.2009.06.015Get rights and content

Section snippets

Genetics

The heterogeneous nature of nonsyndromic familial CRC suggests the coexistence of diverse pathogenic mechanisms. Potential genetic models range from a handful of modest risk alleles to a very large number of small risk alleles, which is the so-called polygenic model of complex diseases.8

Several candidate genes have been considered. In an initial approach, research efforts were made to investigate the involvement of more common, less penetrant genetic variants of known genes responsible for the

Screening Considerations

First-degree relatives of patients with CRC have a 2- to 3-fold increased risk of developing this neoplasm, compared with the overall population (reviewed by Burt and Neklason2; Figure 1). Likewise, it has been found that CRC risk in persons with an affected first-degree relative is approximately the same at age 40 as the general population at age 50.35

From a clinical perspective, the familial risk of CRC depends mainly on the number of relatives, the kinship, and the age of cancer diagnosis.

Therapeutic Implications

Many studies have demonstrated that family history of CRC increases the risk of developing the disease by 2- or 3-fold.35, 37, 41 However, there is controversy over whether a family history of CRC affects the outcome of patients with established disease. A recent study42 demonstrated that a family history of CRC is associated with a significant reduction in cancer recurrence and death among patients with stage III colon cancer receiving adjuvant chemotherapy. In fact, compared with patients

Conclusion

Although it is likely that syndromic entities with a Mendelian inheritance may emerge from the heterogeneous category of familial CRC, predisposition to such a neoplasm in this setting seems to be due to common, low-penetrance genetic components. Genetic testing involving the identified susceptibility genes or others could soon become part of the clinical armamentarium for assessing CRC risk and determining the optimal diagnostic, therapeutic, and preventive approaches. Indeed, identification

First page preview

First page preview
Click to open first page preview

References (44)

  • A. Castells et al.

    Clinical guidelines for the prevention of colorectal cancer

    Gastroenterol Hepatol

    (2004)
  • A.K. Rustgi

    The genetics of hereditary colon cancer

    Genes Dev

    (2007)
  • V. Piñol et al.

    Frequency of hereditary non-polyposis colorectal cancer and other colorectal cancer familial forms in SpainA multicenter, prospective, nation-wide study

    Eur J Gastroenterol Hepatol

    (2004)
  • R.S. Houlston et al.

    The search for low-penetrance cancer susceptibility alleles

    Oncogene

    (2004)
  • N.M. Lindor et al.

    Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X

    JAMA

    (2005)
  • X. Llor et al.

    Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway

    Clin Cancer Res

    (2005)
  • T. Koessler et al.

    Common variants in mismatch repair genes and risk of colorectal cancer

    Gut

    (2008)
  • N. Al-Tassan et al.

    Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors

    Nat Genet

    (2002)
  • O.M. Sieber et al.

    Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH

    N Engl J Med

    (2003)
  • M.A. Jenkins et al.

    Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study

    Cancer Epidemiol Biomarkers Prev

    (2006)
  • M.E. Croitoru et al.

    Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk

    J Natl Cancer Inst

    (2004)
  • V. Pinol et al.

    Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer

    JAMA

    (2005)
  • Cited by (61)

    • Colorectal cancer screening

      2015, Gastroenterologia y Hepatologia
    View all citing articles on Scopus

    Conflicts of interestThe authors disclose no conflicts.

    Funding Supported by grants from the Ministerio de Educación y Ciencia (SAF 07-64873), Asociación Española contra el Cáncer (Fundación and Junta de Barcelona), Fondo de Investigación Sanitaria (05/0071 and 08/0024), Acción Transversal de Cáncer (Instituto de Salud Carlos III), Fundación Olga Torres, and Fundación de Investigación Médica Mutua Madrileña,. CIBERehd is funded by the Instituto de Salud Carlos III.

    View full text